The future of CAR T therapy is promising, with ongoing research aimed at improving its efficacy and expanding its use to a wider range of cancers. Scientists are exploring ways to enhance the persistence and activity of CAR T-cells, reduce side effects, and develop CAR T therapies for solid tumors. Advances in gene-editing technologies, such as CRISPR, are also being investigated to create more precise and effective CAR T-cell therapies.
